In vitro antimicrobial activity of non‐traditional therapies for infectious endometritis in mares
Equine Veterinary Journal · 2025
DOI: 10.1111/evj.14423 ↗Kurz gefasst
Fachartikel in der Zeitschrift Equine Veterinary Journal, 2025. Verfasst von Mariana P Mazzuchini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois Urbana-Champaign, Champaign, Illinois, USA. Hauptthemen laut MEDLINE: Endometritis, Horse Diseases, Anti-Bacterial Agents, Bacteria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: São Paulo Research Foundation (FAPESP), Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Background
Endometritis is the leading cause of subfertility in horses, and it is a clinical problem where historically antibiotics have not always been used with prudent justification. Because of this, alternative therapies to treat endometritis are necessary for the rational use of antibiotics.
Objectives
To assess the in vitro antimicrobial activity of non‐traditional therapies commonly used in clinical practice against microorganisms causing infectious endometritis in mares. Study design In vitro experiments.
Methods
A microdilution technique was performed to determine the minimum inhibitory concentrations (MIC) of 50%, 90% and 100% of microorganisms and the percentage of inhibition (PI) of each therapy against each microorganism ( Escherichia coli , Pseudomonas aeruginosa , Klebsiella pneumoniae , Staphylococcus aureus and Candida sp.). The MIC 50% and 90% were determined using non‐linear regression, while MIC 100% was assessed using the resazurin dye technique. The serial PI was evaluated for each therapy using a spectrophotometer.
Results
All the therapies demonstrated a PI higher than positive controls for all microorganisms ( p < 0.05); however, the only therapies that presented MIC 100 values were hydrogen peroxide and platelet‐rich and ‐poor plasma. Main limitations In vivo, safety and treatment efficacy were not tested.
Conclusion
Hydrogen peroxide and platelet‐rich and ‐poor plasma might be alternatives to traditional therapies for endometritis to support a reduction in antibiotic use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois Urbana-Champaign, Champaign, Illinois, USA.
- Department of Animal Reproduction and Veterinary Radiology, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil.
- Institute of Biotechnology, University of Caxias do Sul (UCS), Caxias do Sul, Rio Grande do Sul, Brazil.
- Ross University School of Veterinary Medicine, Basseterre, St. Kitts, West Indies.
ORCID-Profile: Mariana P Mazzuchini, Fernando Paixão Lisboa, Jessica I de Castro, Marco A Alvarenga, Lorenzo G T M Segabinazzi, Igor F Canisso
Förderung
- São Paulo Research Foundation (FAPESP)
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Mazzuchini, M. P., Lisboa, F. P., de Castro, J. I., Alvarenga, M. A., Segabinazzi, L. G. T. M., & Canisso, I. F. (2025). In vitro antimicrobial activity of non‐traditional therapies for infectious endometritis in mares. Equine Veterinary Journal. https://doi.org/10.1111/evj.14423
Vancouver
Mazzuchini MP, Lisboa FP, de Castro JI, Alvarenga MA, Segabinazzi LGTM, Canisso IF. In vitro antimicrobial activity of non‐traditional therapies for infectious endometritis in mares. Equine Veterinary Journal. 2025. doi:10.1111/evj.14423
BibTeX
@article{Mazzuchini2025,
author = {Mazzuchini, Mariana P and Lisboa, Fernando Paixão and de Castro, Jessica I and Alvarenga, Marco A and Segabinazzi, Lorenzo G T M and Canisso, Igor F},
title = {In vitro antimicrobial activity of non‐traditional therapies for infectious endometritis in mares},
journal = {Equine Veterinary Journal},
year = {2025},
doi = {10.1111/evj.14423}
}
EUVIMED